Chang, Kenneth J <br/><br/>
Phase I evaluation of TNFerade biologic plus chemoradiotherapy before esophagectomy for locally advanced resectable esophageal cancer.  [electronic resource] 

 -  Gastrointestinal endoscopy  Jun 2012 
 - 1139-46.e2 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1097-6779 
<br/><br/><label>Standard No.: </label>10.1016/j.gie.2012.01.042  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--diagnostic imaging<br/>Adult<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Carcinoma, Squamous Cell--diagnostic imaging<br/>Chemoradiotherapy, Adjuvant--adverse effects<br/>Chills--etiology<br/>Cisplatin--administration & dosage<br/>Disease-Free Survival<br/>Dose Fractionation, Radiation<br/>Endosonography<br/>Esophageal Neoplasms--diagnostic imaging<br/>Esophagectomy<br/>Esophagitis--etiology<br/>Fatigue--etiology<br/>Female<br/>Fever--etiology<br/>Fluorouracil--administration & dosage<br/>Humans<br/>Injections, Intralesional<br/>Kaplan-Meier Estimate<br/>Karnofsky Performance Status<br/>Male<br/>Maximum Tolerated Dose<br/>Middle Aged<br/>Nausea--etiology<br/>Neoadjuvant Therapy--adverse effects<br/>Thromboembolism--etiology<br/>Transduction, Genetic<br/>Tumor Necrosis Factor-alpha--administration & dosage<br/>Ultrasonography, Interventional<br/>Vomiting--etiology<br/>Young Adult